Role of Humoral Immunity in Host Defense Against HIV |
| |
Authors: | Linda L Baum |
| |
Institution: | (1) Department of Immunology/Microbiology, Rush University Medical Center, 1735 West Harrison Street, 622 Cohn Building, Chicago, IL 60612, USA |
| |
Abstract: | Individuals infected with HIV-1 and nearly everyone vaccinated with HIV-1 vaccines will, in time, generate antibodies against
viral proteins. These antibodies do not resolve natural infection, and vaccine candidates that successfully stimulate the
production of high titers of neutralizing antibodies have failed to protect against infection. In spite of this, antibodies
continue to be a focus of vaccine research. One reason for the continued interest in antibodies is the failure of a vaccine
engineered to generate cell-mediated immunity against HIV. Successful protective immunity against most intracellular pathogens
involves several arms of the immune response. A successful vaccine should also stimulate both protective cell-mediated immunity
and specific antibody. Efforts should be directed toward making a vaccine that will stimulate the production of 1) more antibody,
2) more broadly cross-reactive neutralizing antibody (broadly neutralizing antibodies), and 3) antibody with a particular
functional activity (antibody-dependent cell-mediated cytotoxicity; catalytic antibodies). |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|